Nazila Heidari

29PUBLICATIONS
80CO-AUTHORS
Toxicology (incl. clinical toxicology)Major global burdens of diseaseAutoimmunityMolecular medicinePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 10, 2026
Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.

|Aug 08, 2026
Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS).

|Jul 08, 2026
An unusual presentation of abdominopelvic inflammatory myofibroblastic tumor in an adolescent male: a rare case report.

|May 23, 2026
RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases.

|Mar 05, 2026
Efficacy and safety of denosumab biosimilars in the treatment of postmenopausal osteoporosis: A systematic review of randomized clinical trials.

Fatemeh Shakibaei, Sepehr Malekshahi, Nazila Heidari

|Jan 02, 2026
Predictors of 12-Month MACE Among Diabetic, Prediabetic, and Normoglycemic Patients Undergoing Elective Percutaneous Coronary Intervention: 10 Years' Experience From Tehran Heart Center.

Ali Hosseinsabet, Nasrin Etesamifard, Akbar Shafiee

Pageof 5

Frequent Collaborators

27 joint publications

Amirhossein Heidari

16 joint publications

Yekta Ghane

9 joint publications

Mohammad Ali Nilforoushzadeh

6 joint publications

Niloufar Najar Nobari